Return to CBI Antibody Core Home Page
  Return to others list
    Return to Sac. erythraea ( Saccharopolyspora erythraea ) list


Sac. erythraea ( Saccharopolyspora erythraea )
eryA1


Links to multiple antibodies on this page for eryA1:
DEBS1
DEBS1

Antibody Name/Abbreviation: DEBS1
CBI Antibody Core Code: A1273a

"Lot" Number: 1 Position: 100 (2-101)
% Identical Homology of Target to Mouse Protein: 32% (NP_036173.1| immunoglobulin superfamily containing leucine-rich repeat)
Molecular Weight of fusion protein: 25 KDa

Target sequence used to make this antibody:
ADLSKLSDSRTAQPGRIVRPWPLSGCNESALRARARQLRA
HLDRFPDAGVEGVGAALAHDEQADAGPHRAVVVASSTSEL
LDGLAAVADGRPHASVVRGV






Antibody Name/Abbreviation: DEBS1
CBI Antibody Core Code: A1273b

"Lot" Number: 1 Position: 100 (1460-1559)
% Identical Homology of Target to Mouse Protein: 35% (NP_031861.1| dynactin 1; dynactin 1, retrograde axonal transport)
Molecular Weight of fusion protein: 25 KDa

Target sequence used to make this antibody:
RPTGAGEPARLDGTWLVAKYAGTADETSTAAREALESAGA
RVRELVVDARCGRDELAERLRSVGEVAGVLSLLAVDEAEP
EEAPLALASLADTLSLVQAM






Sequence Name: eryA1
Full name:
UniGene Number: N.A.
Accession Number: N.A.
Source organism: Sac. erythraea ( Saccharopolyspora erythraea )
Full length size (aa): 3543
NCBI information page:

Full length sequence:
MADLSKLSDSRTAQPGRIVRPWPLSGCNESALRARARQLRAHLDRFPDAG
VEGVGAALAHDEQADAGPHRAVVVASSTSELLDGLAAVADGRPHASVVRG
VARPSAPVVFVFPGQGAQWAGMAGELLGESRVFAAAMDACARAFEPVTDW
TLAQVLDSPEQSRRVEVVQPALFAVQTSLAALWRSFGVTPDAVVGHSIGE
LAAAHVCGAAGAADAARAAALWSREMIPLVGNGDMAAVALSADEIEPRIA
RWDDDVVLAGVNGPRSVLLTGSPEPVARRVQELSAEGVRAQVINVSMAAH
SAQVDDIAEGMRSALAWFAPGGSEVPFYASLTGGAVDTRELVADYWRRSF
RLPVRFDEAIRSALEVGPGTFVEASPHPVLAAALQQTLDAEGSSAAVVPT
LQRGQGGMRRFLLAAAQAFTGGVAVDWTAAYDDVGAEPGSLPEFAPAEEE
DEPAESGVDWNAPPHVLRERLLAVVNGETAALAGREADAEATFRELGLDS
VLAAQLRAKVSAAIGREVNIALLYDHPTPRALAEALAAGTEVAQRETRAR
TNEAAPGEPVAVVAMACRLPGGVSTPEEFWELLSEGRDAVAGLPTDRGWD
LDSLFHPDPTRSGTAHQRGGGFLTEATAFDPAFFGMSPREALAVDPQQRL
MLELSWEVLERAGIPPTSLQASPTGVFVGLIPQEYGPRLAEGGEGVEGYL
MTGTTTSVASGRIAYTLGLEGPAISVDTACSSSLVAVHLACQSLRRGESS
LAMAGGVTVMPTPGMLVDFSRMNSLAPDGRCKAFSAGANGFGMAEGAGML
LLERLSDARRNGHPVLAVLRGTAVNSDGASNGLSAPNGRAQVRVIQQALA
ESGLGPADIDAVEAHGTGTRLGDPIEARALFEAYGRDREQPLHLGSVKSN
LGHTQAAAGVAGVIKMVLAMRAGTLPRTLHASERSKEIDWSSGAISLLDE
PEPWPAGARPRRAGVSSFGISGTNAHAIIEEAPQVVEGERVEAGDVVAPW
VLSASSAEGLRAQAARLAAHLREHPGQDPRDIAYSLATGRAALPHRAAFA
PVDESAALRVLDGLATGNADGAAVGTSRAQQRAVFVFPGQGWQWAGMAVD
LLDTSPVFAAALRECADALEPHLDFEVIPFLRAEAARREQDAALSTERVD
VVQPVMFAVMVSLASMWRAHGVEPAAVIGHSQGEIAAACVAGALSLDDAA
RVVALRSRVIATMPGNKGMASIAAPAGEVRARIGDRVEIAAVNGPRSVVV
AGDSDELDRLVASCTTECIRAKRLAVDYASHSSHVETIRDALHAELGEDF
HPLPGFVPFFSTVTGRWTQPDELDAGYWYRNLRRTVRFADAVRALAEQGY
RTFLEVSAHPILTAAIEEIGDGSGADLSAIHSLRRGDGSLADFGEALSRA
FAAGVAVDWESVHLGTGARRVPLPTYPFQRERVWLEPKPVARRSTEVDEV
SALRYRIEWRPTGAGEPARLDGTWLVAKYAGTADETSTAAREALESAGAR
VRELVVDARCGRDELAERLRSVGEVAGVLSLLAVDEAEPEEAPLALASLA
DTLSLVQAMVSAELGCPLWTVTESAVATGPFERVRNAAHGALWGVGRVIA
LENPAVWGGLVDVPAGSVAELARHLAAVVSGGAGEDQLALRADGVYGRRW
VRAAAPATDDEWKPTGTVLVTGGTGGVGGQIARWLARRGAPHLLLVSRSG
PDADGAGELVAELEALGARTTVAACDVTDRESVRELLGGIGDDVPLSAVF
HAAATLDDGTVDTLTGERIERASRAKVLGARNLHELTRELDLTAFVLFSS
FASAFGAPGLGGYAPGNAYLDGLAQQRRSDGLPATAVAWGTWAGSGMAEG
PVADRFRRHGVIEMPPETACRALQNALDRAEVCPIVIDVRWDRFLLAYTA
QRPTRLFDEIDDARRAAPQAAAEPRVGALASLPAPEREKALFELVRSHAA
AVLGHASAERVPADQAFAELGVDSLSALELRNRLGAATGVRLPTTTVFDH
PDVRTLAAHLAAELGGATGAEQAAPATTAPVDEPIAIVGMACRLPGEVDS
PERLWELITSGRDSAAEVPDDRGWVPDELMASDAAGTRRAHGNFMAGAGD
FDAAFFGISPREALAMDPQQRQALETTWEALESAGIPPETLRGSDTGVFV
GMSHQGYATGRPRPEDGVDGYLLTGNTASVASGRIAYVLGLEGPALTVDT
ACSSSLVALHTACGSLRDGDCGLAVAGGVSVMAGPEVFTEFSRQGALSPD
GRCKPFSDEADGFGLGEGSAFVVLQRLSDARREGRRVLGVVAGSAVNQDG
ASNGLSAPSGVAQQRVIRRAWARAGITGADVAVVEAHGTGTRLGDPVEAS
ALLATYGKSRGSSGPVLLGSVKSNIGHAQAAAGVAGVIKVLLGLERGVVP
PMLCRGERSGLIDWSSGEIELADGVREWSPAADGVRRAGVSAFGVSGTNA
HVIIAEPPEPEPVPQPRRMLPATGVVPVVLSARTGAALRAQAGRLADHLA
AHPGIAPADVSWTMARARQHFEERAAVLAADTAEAVHRLRAVADGAVVPG
VVTGSASDGGSVFVFPGQGAQWEGMARELLPVPVFAESIAECDAVLSEVA
GFSVSEVLEPRPDAPSLERVDVVQPVLFAVMVSLARLWRACGAVPSAVIG
HSQGEIAAAVVAGALSLEDGMRVVARRSRAVRAVAGRGSMLSVRGGRSDV
EKLLADDSWTGRLEVAAVNGPDAVVVAGDAQAAREFLEYCEGVGIRARAI
PVDYASHTAHVEPVRDELVQALAGITPRRAEVPFFSTLTGDFLDGTELDA
GYWYRNLRHPVEFHSAVQALTDQGYATFIEVSPHPVLASSVQETLDDAES
DAAVLGTLERDAGDADRFLTALADAHTRGVAVDWEAVLGRAGLVDLPGYP
FQGKRFWLLPDRTTPRDELDGWFYRVDWTEVPRSEPAALRGRWLVVVPEG
HEEDGWTVEVRSALAEAGAEPEVTRGVGGLVGDCAGVVSLLALEGDGAVQ
TLVLVRELDAEGIDAPLWTVTFGAVDAGSPVARPDQAKLWGLGQVASLER
GPRWTGLVDLPHMPDPELRGRLTAVLAGSEDQVAVRADAVRARRLSPAHV
TATSEYAVPGGTILVTGGTAGLGAEVARWLAGRGAEHLALVSRRGPDTEG
VGDLTAELTRLGARVSVHACDVSSREPVRELVHGLIEQGDVVRGVVHAAG
LPQQVAINDMDEAAFDEVVAAKAGGAVHLDELCSDAELFLLFSSGAGVWG
SARQGAYAAGNAFLDAFARHRRGRGLPATSVAWGLWAAGGMTGDEEAVSF
LRERGVRAMPVPRALAALDRVLASGETAVVVTDVDWPAFAESYTAARPRP
LLDRIVTTAPSERAGEPETESLRDRLAGLPRAERTAELVRLVRTSTATVL
GHDDPKAVRATTPFKELGFDSLAAVRLRNLLNAATGLRLPSTLVFDHPNA
SAVAGFLDAELGTEVRGEAPSALAGLDALEAALPEVPATEREELVQRLER
MLAALRPVAQAADASGTGANPSGDDLGEAGVDELLEALGRELDGD





Questions? Click here for answers.


© Monday, February 16, 2009 by the CBI Antibody Core and the Center for Biomedical Inventions, University of Texas Southwestern Medical School.